The US Food and Drug Administration (FDA) has approved hyaluronic acid dermal filler Restylane Lyft for cheek augmentation and the correction of age-related mid-face contour deficiencies via small blunt tip cannula in patients over the age of 21.
Pharmaceutical company Galderma will be hosting a free, two-hour webinar on the Aesthetics Media website between 7-9pm on March 11.
Two of the industry’s leading companies could become one if a multi-million dollar bid by Galderma to acquire Q-Med goes ahead. In a joint venture between L’Oreal and Nestle. Galderma, the makers of Azzalure®, launched a reported $970 million bid for the Swedish manufacturer of Restylane® at the end of 2010.
Pharmaceutical company Galderma has launched a global consumer campaign that aims to build trust in aesthetic treatments.
International pharmaceutical company Galderma has expanded the Galderma Aesthetics Academy Faculty with more key opinion leaders joining the team. The Faculty will also be refining a series of masterclasses with a focus on treatment selection for both the full face and individual features, like the lips.
The Food and Drug Administration (FDA) has approved Restylane Refyne and Restylane Defyne dermal fillers from Galderma for the treatment of nasolabial folds.
Pharmaceutical company Galderma (UK) Limited has confirmed that aesthetic and skincare product supplier Med-fx Ltd will become the company’s preferred distributor, subject to contract, for its aesthetics portfolio.
International pharmaceutical company Galderma has launched a new hologram on all packaging across the entire Restylane portfolio of Non-Animal Stabilised HA (NASHA) and Optimal Balance Technology (OBT) products, as well as the Skinboosters range to provide practitioners with further assurance that the products are original.
Pharmaceutical company Galderma has launched a new dermal filler winter marketing campaign to support its customers in promoting their business in the run-up to the festive period.
Due to unforeseen circumstances, The Anatomy of the Smile Webinar sponsored by pharmaceutical company Galderma has been postponed until March 11.